Human Psychopharmacology

SJR Rank #8,809H-index: 89SJR: 0.662Best quartile: Q2APC: US$4,030
Journal website: aims, scope and author guidelines
Publisher

John Wiley and Sons Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Neurology (clinical)Q2
  • Pharmacology (medical)Q2
  • Psychiatry and Mental HealthQ2
  • NeurologyQ3

Areas: Medicine · Neuroscience

Most published research topics

Treatment of Major DepressionSchizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorAttention Deficit Hyperactivity DisorderAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesBipolar Disorder and TreatmentTryptophan and brain disordersElectroconvulsive Therapy StudiesForensic Toxicology and Drug AnalysisSleep and related disorders

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0255075100

Documents per Year

20222025015304560

Detailed Information

ISSN

1099-1077, 0885-6222

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

1.89

References per Document

46.96

Coverage

1986-2026

Scope

No scope description available yet.

Metrics from SCImago Journal Rank 2025. View on SCImago